BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Policy

  Internal Memo Reveals Bristol-Myers Squibb to Stop Paying Speaker Fees to Doctors in China Due to Possible Violations of Company Policies

  March 8, 2016

   · 

  2 min read
• 

  Deals

  Analyst Mulls Over The Possibility of Shire Acquiring Biogen

  March 8, 2016

   · 

  3 min read
• 

  Deals

  Amgen on the Prowl for Bigger M&As

  March 8, 2016

   · 

  3 min read
• 

  Business

  Bay Area’s Tizona Therapeutics Emerges from Stealth Mode with $70 Million Total in Financing

  March 8, 2016

   · 

  2 min read
• 

  Drug Development

  Breast Cancer Pipeline Has More than 1,000 Drugs in Development

  March 8, 2016

   · 

  3 min read
• BioMidwest

  Tiny Origami-Inspired Devices Make Surgery Without Stitches A Possibility, Brigham Young University Study

  March 8, 2016

   · 

  2 min read
• Health Tech Startup Sees Hearing Test Market As Ripe For Disruption

  March 8, 2016

   · 

  1 min read
• Eating Peanuts Early Helps Reduce Allergy Risk, King’s College London Study

  March 8, 2016

   · 

  4 min read
• Genetown

  Amid Mixed Signals, Evidence Hints At A Biotech Comeback

  March 8, 2016

   · 

  1 min read
• 

  Policy

  Gilead, Merck & Co. Duke It Out Over Hep C $1,000-Pill Royalties

  March 8, 2016

   · 

  3 min read